Mary Lor
Celerion (United States)(US)Celerion (Canada)(CA)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Pain Management and Opioid Use, Food Allergy and Anaphylaxis Research, Advancements in Transdermal Drug Delivery, Allergic Rhinitis and Sensitization
Most-Cited Works
- → Pharmacokinetics, Tolerability, and Performance of a Novel Matrix Transdermal Delivery System of Fentanyl Relative to the Commercially Available Reservoir Formulation in Healthy Subjects(2006)51 cited
- → Comparative bioequivalence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation(2006)26 cited
- → Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants(2024)11 cited
- → A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector(2023)10 cited
- → Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion(2024)10 cited
- → Pharmacokinetics, safety and tolerability of a novel 100 ?g/h transdermal fentanyl patch co-administered with 100 mg oral naltrexone in healthy males(2005)3 cited
- → Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants(2024)3 cited
- → Evaluating the Effect of Silibinin on the Expression of Pannexin1 Gene During Hepatic Ischemia-Reperfusion(2022)2 cited
- → Pharmacokinetics and Safety of Repeat Dosing with Epinephrine Nasal Spray in Healthy Adults(2024)1 cited
- → 13.2 MG INTRANASAL EPINEPHRINE TREATMENT IN CONGESTION SHOWS INCREASED BIOAVAILABILITY WITHOUT PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATION(2023)